Laxmi Dental Q4 FY26 Earnings Call Transcript Released
Laxmi Dental's Q4 FY26 revenue reached ₹74 crore (up 22% YoY). Full-year revenue was ₹277.9 crore (up 16.2% YoY). The company launched the iScope 360 platform and reported strong performance in its dental lab business. Scanners placed in Q4 were 211, with 1009 for the year. The company remains debt-free.
The announcement provides a detailed earnings call transcript which includes financial performance and strategic updates. While positive, it does not contain any groundbreaking new information or immediate significant corporate actions that would dramatically alter the company's valuation.
The company reported strong financial results with significant year-on-year growth in revenue and healthy profit margins. The launch of a new AI-driven platform and strategic initiatives indicate a positive outlook.
Laxmi Dental Limited has released the transcript of its Q4 FY26 earnings conference call, which was held on May 22, 2026, at 10:00 AM IST. The call, organized by Motilal Oswal Financial Services, discussed the company's audited financial results for the quarter and financial year ended March 31, 2026.
During the call, the management reported that Q4 FY26 saw the highest ever quarterly numbers across key metrics, with revenue standing at ₹74 crore, a year-on-year growth of 22%. Gross profit margin was 70.5%. EBITDA and PAT margins were reported at 18.3% and 13.6% respectively. For the full fiscal year FY26, revenue grew by 16.2% year-on-year to ₹277.9 crore, with EBITDA margins at 15.6% and PAT at 10.4%. The company also highlighted strategic initiatives like the launch of the AI-connected remote dental platform, iScope 360, and continued investment in digital dentistry.
The dental lab business achieved its highest ever quarterly revenue of ₹45.9 crore, with international operations growing by 40.9% year-on-year. The aligner solutions business, including Bizdent (clear aligners) and Vedia (raw metal), showed stable performance. The company also reported placing 211 scanners in Q4 FY26, bringing the yearly total to 1009. The US business constitutes about 20% of the company's revenue, with tariffs normalizing to approximately 10%. The company remains debt-free with cash and bank balances of around ₹99 crore. CAPEX for FY26 was ₹18.4 crore, and future CAPEX will be deployed based on operational capabilities.
What to do with a filing like this
Laxmi Dental Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Laxmi Dental Limited. Read the original for the full detail.